Probiotic therapy to men with incipient arteriosclerosis initiates increased bacterial
In biology, it is a general consensus that a high diversity of organisms is beneficial for the 52 ecosystem on both global and local levels. A high diversity indicates an ecosystem in healthy 53 balance and it provides a higher resilience to ecological disturbances which also applies for 54 microbial ones. 1 In contrast, an unbalanced, disturbed, or diseased ecosystem opens up for 55 "overgrowth" of a few organisms, and contributes to further disturbances and new diseased 56 conditions, a fact valid for the microbial ecosystem of the human gut.
2 For example, it has 57 been shown that patients with Crohn's disease and ulcerative colitis have low bacterial 58 diversity in the gastro-intestinal (GI) tract.
3, 4 Furthermore, infants with low bacterial diversity 59 in faeces at one week of age more frequently develop atopic eczema after 18 months. The bacterial flora of the GI-tract makes up a complex ecosystem and the composition and 62 activity of the different bacterial groups play important roles for the health status due to its 63 contribution to, for example, nutrition, colonisation resistance, and development and tuning of 64 the immune system. 6 Pro-inflammatory components of the resident microbiota can increase 65 the permeability of the mucosal barrier and cause subclinical inflammation. Cardiovascular diseases (CVD) attributes one-third of all global deaths. 8 The aetiology is not 68 fully understood but obesity, high blood pressure, physical inactivity and a diet high in 69 saturated fats, salt and refined carbohydrates have been shown to increase the risk to develop 70 CVD. 8 Oxidative stress and oxidation of low-density lipoprotein (LDL) are important factors 71 involved in the chronic inflammation of the arteries and atherosclerosis onset. starting the disease is not fully understood and microbial components signalling through toll-74 like receptors (TLRs) may play a role. 10 Enhanced expression of TLRs has been shown in 75 human atherosclerotic plaques.
11 Previously, Chlamydia pneumonie has been associated with 76 increased risk of CVD 12 and it has been hypothesised that live bacteria colonise the artery 77 wall and initiate infection leading to atherosclerosis. But this has been hard to prove and a 78 refined version of the infection hypothesis focuses on pathogen-associated molecular patterns 79 (PAMPs). Bacterial molecules e.g. lipopolysaccharides, flagellin and bacterial lipopeptide are 80 examples of PAMPs that bind to TLRs and initiate signalling.
10 Disruption of the epithelial 81 tight junctions can be mediated by inflammatory mediators and the consequence will be 82 increased intestinal translocation during inflammatory conditions. 13 PAMPs from the GI-83 microbiota can translocate through the intestinal epithelial cell layer into the circulation, even 84 in relatively healthy persons, 14 making this process to one of many possible explanation to the 85 origin of atherosclerosis onset. Furthermore, bacterial overgrowth in the intestine increases 86 the translocation, 15 highlighting the importance of a balanced microbiota. 87
88
The bacterial species L. plantarum frequently occurs spontaneously and in high numbers in 89 most lactic acid fermented foods, especially when based on plant material, for example, in 90 brined olives, capers, sauerkraut, salted gherkins and sourdough. 16 However, L. plantarum is 91 also present on human oral and intestinal mucosa. 17 The strain L. plantarum DSM 9843 has 92 been isolated from healthy human intestinal mucosa 17 and is by now a well studied probiotic 93 strain used in a number of human studies. 18, 19 Intake of this strain in a rosehip drink has 94 shown to affect the intestinal environment by effects on the short-chain fatty acid content 95 (SCFA).
19 L. plantarum DSM 9843 also attaches to human mucosa cells by a mannose-96 dependent adherence mechanism, 20 which favour persistence and close interaction with the 97 host. The concept of probiotics implies that the balance between beneficial and harmful 98 bacteria in the GI-microbiota can be positively affected by eating the right type of living 99 microorganisms. This is in line with the present study where the aim was to clarify the 100 microbial change in the intestinal microbiota in subjects, with well-controlled CVD, 101
consuming an oat drink, with either L. plantarum DSM 9843 or without bacteria. Different 102 blood parameters, markers for systemic inflammation included, and the profile of SCFA in 103 faeces were measured. To our knowledge, this is the first time it has been shown that 104 consumption of a single probiotic strain can increase the diversity of the resident, dominating, 105 intestinal microbiota. University. Men on antibiotic therapy or presence of infections at the time of study onset, or 120 within four weeks prior to inclusion, were not included in the study. The subjects had neither 121 ongoing intestinal disease, autoimmune disease, nor highly increased plasma concentration of 122 inflammatory blood markers, but values for C-reactive protein varied highly among the 123 patients. Medications and diagnoses are described in Table 1 . The median age of subjects 124 receiving active therapy was 70 (range 60-75), and 67 (range 58-74) years in the placebo 125 group. Nine of the subjects consumed oat drink fermented with L. plantarum DSM 9843 (= 126 299v; Probi AB, Lund, Sweden). The active growth of the bacteria in the product 127 (fermentation) granted high numbers of active bacteria. Seven subjects consumed the placebo 128 product, which was an unfermented oat drink (without any L. plantarum) where pH had been 129 adjusted, by addition of lactic acid, according to that of the fermented one. The products were 130 produced and packed by Skane Dairy (Malmö, Sweden). Products were consumed daily, 131 100 ml per day for four weeks. For the probiotic group the daily intake of L. plantarum 132 DSM 9843 was 10 11 colony forming units (CFU). The volunteers were not allowed to ingest 133 any foods containing lactobacilli with known probiotic effects two weeks before start of 134 consumption of test products nor during the study. Patients were asked to not ingest olives, 135 sauerkraut, pickled raw salmon or gherkin, salami or German sausage, but no other dietary 136 restrictions were applied. Rigid rectoscopy were performed and all biopsies were taken with a 137 sterile forceps at 20 cm from anal verge before and after ingestion of test product for four 138 weeks. Biopsies were stored in TE buffer at -80°C until analysis. Blood samples were taken 139 from one blood vessel in an arm, and blood pressure and heart rate were measured by the 140 research nurse. Subjects reported number of faeces and bowel function in a diary. 141
142

DNA extraction 143
Mucosal biopsies were treated in an ultra sonic bath for 5 minutes, vortexed for 2 minutes and 144 transferred to sterile UV treated tubes and centrifuged at 9 000 rpm for 7 min. Buffer G2 145 (380 µl) and 30 µl Proteinas K (Qiagen, Hilden, Germany) were added to the pellet and the 146 samples were treated in water bath at 56ºC until totally dissolved. The suspension were 147 further disintegrated by shaking together with 12-15 glass beads (2 mm in diameter) for 148 45 minutes at 4ºC in an Eppendorf Mixer (model 5432, Eppendorf, Hamburg, Germany). total volume of 10 µl. The enzymes were inactivated at 65ºC for 15 min and digestion 177 products were treated as previously described, 5 except for the internal size standards that 178 contained Cy5-ENV1 primer, 20 basepairs (bp), and 697 bp PCR product amplified from 179 E. coli ATCC 11775 by using primer 685r (5´-TCT ACG CAT TTC ACC GCT AC-3´; 180 E. coli numbering 705-685) and Cy5-ENV1. External size standards were used as previously 181 described. 5 The labelled fragments were separated and detected with an ALFexpress II DNA 182 sequencer with a 7 % ReproGel Long Read gel (GE Healthcare, Uppsala, Sweden) for 183 700 min under the following conditions: 1500 V, 60 mA, and 55ºC. 184 185
Diversity analysis 186
The peak areas of fluorescently labelled T-RFs were estimated by using ALFwin™ Fragment 187 The amounts of SCFA in faeces were analysed by capillary gas-liquid chromatography after 203 silylation.
22 Samples were homogenized with 2-ethylbutyric acid (internal standard), 204 hydrochloric acid was added to protonise the acids and then the SCFA were extracted with 205 (Table 2) . 237
For the probiotic group the individual intestinal diversity was higher compared to the diversity 238 before the start of consumption. The change in diversity was significantly different between 239 the probiotic group and the placebo group, both when Shannon and Simpson indices were 240 calculated ( Table 2) . 241
242
Since more than one bacterial group can present T-RFs of the same length when cut with one 243 enzyme, two restriction endonucleases were used when analysing the intestinal ecosystem. In 244 the current study MspI and HaeIII were used, both showing higher diversity after probiotic 245 treatment but lower after placebo treatment when compared to the individual diversity before 246 study onset (Table 2) . 247
248
The probiotic group had significantly lowered faecal concentration of isovaleric acid 249 (p=0.006) and valeric acid (p=0.029) compared to the placebo group. No other statistically 250 significant changes in concentration of carboxylic acids were observed (Table 3) . 251
252
The probiotic group had significantly higher viable count of lactobacilli at the end of the study 253 than the placebo group (p=0.001). The probiotic group also reported decreased numbers of 254 defecations, compared to the change in the placebo group (p=0.034). No significant 255 differences were observed in the biochemical markers (Table 4) . It has generally been assumed that the composition of the GI-microbiota is stable over time. 269
However, when using molecular genetic methods with high sensitivity it is possible to detect 270 minor microbial changes, for example, changes induced by diet. 25 Increased bacterial load and 271 diversity have been shown in pouchitis patients after administration of a multi-strain probiotic 272 (VSL#3), using culture-independent techniques. 26 However, in the present study 273 administration of a single bacterial strain increased the bacterial diversity of the gut, and to 274 our knowledge this is the first time such a thing has been shown. 275
276
Since each individual gut can be regarded as an individual ecosystem 24 this study accesses the 277 individual change in diversity after consumption of test product. The indices of Shannon and 278
Simpson are well established and are also frequently used to estimate bacterial diversity. Table 2 ). The reason for this effect is 287 unknown but can give rise to several speculations. One explanation may be that 288 L. plantarum DSM 9843 has a relatively large genome and a well developed ability to ferment 289 not only many different carbohydrates but also the ability to split and catabolise polyphenols, 290 which might lead to production of metabolites that affect the living conditions favourably of 291 other groups of bacteria. Another suggested explanation may be that the probiotics improve 292 the condition of the GI-mucosa and a healthy mucosa opens up for a more diverse bacterial 293 flora. Mack et al. 27 have shown increased mucin production by colonic cells when exposed to 294 L. plantarum DSM 9843, a fact that perhaps could influence diversity of the intestinal 295 microbiota. 296
297
Oral consumption of L. plantarum DSM 9843 in a fruit drink has been shown previously to 298 affect the profile of SCFA in faeces of healthy human subjects. 19 This indirectly gives a hint 299 that the microbiota in some way is affected by the probiotic administration. In the present 300 study the change in concentration of SCFA varied between individuals (data not shown) 301 which made it difficult to obtain statistically significant differences between the probiotic 302 group and the placebo group. But still, the probiotic group showed a significantly decrease in 303 the concentrations of isovaleric acid and valeric acid compared to the change in the placebo 304 group (Table 3) . Accumulation of isovaleric acid in plasma is observed in the metabolic 305 disease isovaleric acidemia. Since both isovaleric acid and valeric acid are cytotoxic even at 306 physiological concentrations, 28 it is preferred to have them kept at low levels. Furthermore, 307 patients with celiac disease, an inflammatory disorder, have been reported to have increased 308 levels of both isovaleric acid and valeric acid compared to healthy controls. 29 Thus to a 309 certain extent, these carboxylic acids may be seen as markers for disorders and the decreased 310 levels in persons consuming L. plantarum DSM 9843 might be regarded as beneficial. 
322
It remains to be elucidated, if treatment of this lower diversity also is a means by which to 323 overcome the increased incidence of inflammation. However, in the present cohort of patients 324 no significant changes in blood markers were observed. The patients showed highly 325 individual CRP concentrations, but other inflammatory markers were not remarkable different 326 neither before nor after the study period. 327 328
In conclusion, the present study showed increased diversity of the dominating intestinal 329 microbiota after consumption of a single bacterial strain with probiotic effects. These results 330 should be verified in larger trials. However, the results suggest that administration of 331 presumably is favourable for the condition of the mucosa, and a healthy mucosa decrease the 333 risk of translocating PAMPs that negatively affects atherosclerosis. 334
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